New Delhi. Johnson & Johnson Corona Vaccine In India, the American company Johnson & Johnson has withdrawn the application for early approval of its corona vaccine trial. However, the company has not made public the reason behind this. This information was given by the Drug Regulator of India (DCGI) on Monday. Let us inform that Johnson & Johnson had applied for trial of its vaccine in India in April this year.
Read: – UNSC News: PM Modi is close to creating another history, India will preside over UNSC for a month
The company has not made any official comment regarding this. India is currently facing legal challenges with vaccine manufacturers over safety issues. Minister of State for Health Bharti Praveen Pawar had said in the past that a team has been formed to hold talks with vaccine manufacturers. These issues are with Pfizer, Moderna and Johnson & Johnson.
Let us inform that so far four anti-corona virus vaccines have been allowed for use in India. These include Bharat Biotech’s indigenous vaccine covacin, Oxford-AstraZeneca’s Coveshield, Russia’s Sputnik V and Moderna’s Vaccine. Let us tell you that the vaccine of American company Moderna was given permission for emergency use by DCGI in June itself.